A systemic toxicity index developed to assess peripheral changes in mood episodes Our group and others have put forward a set of targets related to oxidative stress, neurotrophins and inflammation as key mediators of the cognitive and general health impairment that occur with recurrent mood episodes. [1] [2] [3] [4] Here, we report the first en bloc assessment of this set of previously described markers of mood episodes in bipolar disorder. For that, we examined these peripheral biomarkers in different mood states of bipolar disorder and in healthy subjects. Finally, to make the point that these are consequential and potentially ominous changes, we measured the same indicators from patients with sepsis, as a 'positive' control group with an extreme and massive peripheral illness. We termed the end result of this analysis as a systemic toxicity index (STI).
A total of 60 patients with bipolar I disorder, 80 healthy subjects and seven patients with sepsis were recruited (see Table 1 ). Psychiatric diagnoses and the current mood state were confirmed with the Structured Clinical Interview for DSM-IV. Healthy subjects were frequency-matched for age and sex. This group was screened with the non-patient version of the Structured Clinical Interview for DSM-IV to exclude psychiatry morbidity, those who had first-degree relatives with BD, schizophrenia or other psychotic disorders. Seven patients with a clinical diagnosis of sepsis (according to the Consensus Conference of the American College of Chest Physicians and Society of Critical Care Medicine) were recruited from an intensive care unit as a 'positive' control group. All participants gave written informed consent before entering the study, which was approved by the local ethics committee.
All assays presented in the Figure were carried out according to methodology described in previous publications from our group [3] [4] [5] and performed blind to subject group. The three dimensions assessed were neurotrophins (brain-derived neurotrophic factor, neurotrophin-3), oxidative stress markers (protein carbonyl content, thiobarbituric acid reactive substances, total reactive antioxidant potentials) and inflammatory markers (interleukin-6, interleukin-10 and tumor necrosis factor a). The index was designed to summarize the shared variance of diverse biomarkers correlated with mood episodes in bipolar disorder as a proxy of systemic toxicity. To this end, we extracted the first component from a principal component analysis of the above-mentioned markers as the STI and the results are shown in the Figure 1 .
Singh and Rose 6 have argued that the information given by any individual biomarker would have a small effect size in complex disorders. In this report, we set out to evaluate how a composite measure would perform in the separation of acute mood states and control conditions. We found large and significant differences, and these changes were in the same direction-but less pronounced-as in patients with severe sepsis.
These preliminary findings provide the first direct indication of how toxic acute mood episodes can be. This may eventually relate to the loss of years of life expectancy evidenced in patients with bipolar disorder. 7 An emerging body of data points to accelerated aging or 'wear and tear' of bodily systems as taking place in proportion with number of mood episodes or duration of illness. In this fashion, the toxicity related to mood episodes would not be necessarily explained by one particular pathophysiological mechanism. Rather, it may be because of an accumulation of passive and active processes of cellular endangerment related to the failure to set up adequate compensatory mechanisms to deal with environmental challenges. 1, 8 As such, peripheral pathology may mediate much of the relation between acute mood episodes and the well established medical burden of bipolar illness. 9 In this manner, Figure 1 Weighs for the primary component analysis (PCA) and differences in the ensuing systemic toxicity between groups. *For the PCA, NT-3 levels were square root transformed and protein carbonyl content levels were log transformed. As interleukin and TNF levels could not be usefully transformed, they were transformed in eight even ordinal categories. The first component of the PCA was extracted as the index. The PCA was also performed without the sepsis patients as a sensitivity check with negligible differences (not shown). Bartlett's test was highly significant (P < 0.001), indicating the possibility of performing the analysis. All differences between groups significant (P < 0.001) (one-way ANOVA with Bonferroni correction), except for control and euthymia (P = 0.97) and mania and depression (P = 1.00). TBARS, thiobarbituric acid reactive substances; IL-10, interleukin 10; PCC, protein carbonyl content; IL-6, interleukin 6; BDNF, brain-derived neurotrophic factor; TNFa, tumor necrosis factor a; TRAP, total reactive antioxidant potential; NT-3, neurotrophin 3.
mood episodes may ultimately be conceived as toxic to multiple cellular elements in the body, both centrally and systemically. Using a selection of positional susceptibility genes with high 'genetic potential' (i.e., heritability) and information obtained from peripheral gene expression, Rietkerk et al.,
1 reported in the April issue of Molecular Psychiatry different biological pathways 'in which the actions of several of these genes converge,' that highlighted a putative (and consistent) role for myelin-related pathways in the etiology of schizophrenia. The authors' approach to 'define the biological coherence of schizophrenia positional candidate genes' was based on overrepresentation of gene ontology annotations among putative coexpression modules derived from lymphocyte gene microarray data. However, blood and brain (site of disease) transcriptomes show only B0.6 correlation.
2 Moreover, coregulation is a single window into functional relationships, which are overall likely to have been described in the literature, hence resulting in related gene ontology annotations.
3 Therefore, we speculated that a direct functional and clustering analysis of evidence-based literature may be more encompassing, and thus more sensitive to identifying biological clusters of candidate genes within putative etiological pathways of the illness.
To test this hypothesis, we overlaid the set of 766 genes selected by Rietkerk et al. from a combination of linkage studies, brain expression and substantial heritability onto the Ingenuity knowledge database (http://www.ingenuity.com/). This database includes over 2 million hand-curated literature-based links between genes and other bioactive molecules. In a process that was analogous to that of Rietkerk et al, we functionally characterized the top five sub-networks formed by candidate genes, on the basis of their connectivity within the global Ingenuity network (Table 1) and also assessed functions, canonical pathways and diseases/disorders that were otherwise associated with the gene set. Using this different analytical approach and pathway classification methodology, we confirmed the overrepresentation of genes implicated in the metabolism of lipids and sphingolipids (ASAH1, GLB1, NEU1) in two of the top networks, and of other canonical pathways (phospho-Inositol signaling and mitogen-activated protein kinase signaling pathways) identified in the study by Rietkerk et al. (Table 1) . Schizophrenia was among the five disorders to be more likely associated with this set of genes, thus providing an internal validation of the approach.
The most striking difference provided by our more direct approach was the identification (through overrepresentation and redundancy) of gene groups implicated in immunological and inflammatory diseases, auto-immune disease (e.g., rheumatoid arthritis) or canonical pathways related to antigen presentation. These results are consistent with previous evidence that indicated that autoimmune pathologies may be associated with some forms of schizophrenia. 4 Furthermore, in rats, prenatal lipopolysaccharideinduced immune activation leads to altered prepulse inhibition and immune function in adulthood, which are both reversed by antipsychotics. 5 Focusing on this critical neurodevelopmental period, it has also been
